• Channels
    • All News
    • Premium Content
    • In Focus
    • Special
    • AI
    • Bioregnum
    • Biotech Voices
    • Cell/Gene Tx
    • China
    • Coronavirus
    • Deals
    • Diagnostics
    • Discovery
    • FDA+
    • Financing
    • Law
    • Letters to the Editor
    • Manufacturing
    • Marketing
    • Opinion
    • Outsourcing
    • Peer Review
    • People
    • Pharma
    • R&D
    • Startups
    • Weekly
  • Webinars
  • Biopharma Jobs
  • More
    • Work at Endpoints
    • Letter to Editors
    • IPO Tracker
    • Webinars
    • Events
    • Sponsored Posts
    • Advertise
    • Privacy Policy
    • Endpoints Merch
    • About Us
    • Help
  • SIGN UP

Ex­clu­sive: Ver­i­ly wel­comes Atara Bio­ther­a­peu­tics vet­er­an as new CFO

4 hours ago
People
Pharma

Dex­com's spokescelebri­ty Nick Jonas re­turns to Su­per Bowl in new glu­cose mon­i­tor com­mer­cial

5 hours ago
Pharma
Marketing

New Te­va CEO Richard Fran­cis repri­or­i­tizes to 'get back to growth'

5 hours ago
Pharma

DC court over­rules PhRMA's bid to shut down drug im­ports from Cana­da

6 hours ago
Pharma
Law

FDA com­mis­sion­er floats ideas on how to bet­ter han­dle the pan­dem­ic

6 hours ago
FDA+

Sanofi re­news so­cial cam­paign to re­mind that vac­cines let peo­ple ‘Dream Big’

6 hours ago
Pharma
Marketing

Dai­ichi Sankyo to build Japan's first mR­NA vac­cine man­u­fac­tur­ing fa­cil­i­ty — re­port

6 hours ago
Coronavirus
Manufacturing

Bay­er taps Roche's Bill An­der­son to lead phar­ma gi­ant as CEO

6 hours ago
People
Pharma

As­traZeneca moves for­ward with a $360M API plant in Ire­land

7 hours ago
Pharma
Manufacturing

Ovid brings two Big Phar­ma vets on board as new CMO, head of epilep­sy re­search

9 hours ago
People
R&D

Biotech re­ceives award from DOD; Reg­u­la­tors ac­cept Ap­pili Ther­a­peu­tic­s' NDA

10 hours ago
News Briefing

Mer­ck-No­var­tis re­volv­ing door spins again as AI leader Iya Khalil switch­es phar­mas

11 hours ago
People
AI

Af­ter a bad quar­ter, Il­lu­mi­na fo­cus­es on new DNA se­quenc­ing plat­form

11 hours ago
Pharma

How Pur­due's $272M ad­dic­tion pay­out fund­ed a new home for its dis­card­ed non-opi­oid re­search

12 hours ago
Pharma
In Focus

The drug pric­ing pres­i­dent: Biden warns of ve­to for any IRA re­peal at­tempts

14 hours ago
Law

Swiss rare dis­ease biotech with­draws IPO to up­date its Nas­daq plans

14 hours ago
Financing

As clin­i­cal tri­als get more com­plex, soft­ware start­up Faro bags $20M to help vi­su­al­ize them

15 hours ago
Financing
R&D

A small change in your in­box each morn­ing

15 hours ago
Editor's note

FDA as­sem­bles ad­comm to re­view GSK's Jem­per­li tri­al plans in rec­tal can­cer

Yesterday
R&D
FDA+

Re­searchers pan phar­ma DTC ad­ver­tis­ing for high spend­ing on low-val­ue drugs — JA­MA re­port

Yesterday
Pharma
Marketing

#JPM23: This is how we cure can­cer

Yesterday

Biden to tout phar­ma's de­feat in State of the Union, call for $35 in­sulin for all

Yesterday
FDA+
Law

Pfiz­er or­dered to dis­close FBI com­mu­ni­ca­tions in trade se­crets case

Yesterday
Pharma
Law

Pa­tients, ad­vo­ca­cy groups launch fight against Trikaf­ta patents in four coun­tries

Yesterday
Pharma
1234 Next page Last page
Endpoints News

Bioscience & Technology Business Center
The University of Kansas
Lawrence, Kansas

Latest

  • All News
  • Premium Content
  • Don't Miss
  • Special
  • In Focus

Channels

  • AI
  • Bioregnum
  • Biotech Voices
  • Cell/Gene Tx
  • China
  • Coronavirus
  • Deals
  • Diagnostics
  • Discovery
  • FDA+
  • Financing
  • Law
  • Letters to the Editor
  • Manufacturing
  • Marketing
  • Opinion
  • Outsourcing
  • Peer Review
  • People
  • Pharma
  • R&D
  • Startups
  • Weekly

More

  • Work at Endpoints
  • Letter to Editors
  • IPO Tracker
  • Events
  • Webinars
  • Sponsored Posts
  • Advertise
  • Endpoints Merch
  • About Us
  • Help

Work in biotech

  • Endpoints Careers

© Endpoints Company 2023

  • Help
  • Advertise
  • Privacy Policy
  • Business Model
Endpoints News

Log in to your account

e-mail

password

Endpoints News

request magic link

If you're already an Endpoints subscriber, enter your email below for a magic link that lets you log in quickly without using a password. Please note the magic link is one-time use only and expires after 24 hours.

email

Endpoints News

reset password

We'll e-mail you a link to set a new password. Please note this link is one-time use only and is valid for only 24 hours.

email

Endpoints News

About You

Subscriptions

ENDPOINTS NEWS Daily at 11:30 AM ET

EARLY EDITION Daily at 7:15 AM ET

ENDPOINTS PHARMA Daily at 2 PM ET

ENDPOINTS MARKETING RX Tue at 2 PM ET

ENDPOINTS FDA+ Wed at 2 PM ET

ENDPOINTS MANUFACTURING Thu at 2 PM ET

ENDPOINTS WEEKLY Sat at 6 AM ET